Expression of Concern: miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6. . Int J Cancer 2024 Jul 31. doi: 10.1002/ijc.35121.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Expression of Concern: miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6. Int J Cancer 2024 Jul 31. doi: 10.1002/ijc.35121.
PMID: 39081232